Timeline of Schistosomiasis Control Initiative
From Timelines
This is a timeline of Schistosomiasis Control Initiative, a non-profit initiative that works with governments in sub-Saharan African countries to create or scale up programs that treat schistosomiasis and soil-transmitted helminthiasis.[1]
Contents
Big picture
Time period | Development summary |
---|---|
2006 | SCI becomes a founding partner of the Global Network for Neglected Tropical Diseases which promotes integration of control or elimination programmes against seven neglected tropical diseases. |
2007 | SCI facilitates delivery of approximately 40 million treatments of praziquantel against schistosomiasis, and many more deworming doses of albendazole.[2] |
2010 | SCI expands its reach after the award of the management of ICOSA, a programme funded by the Department for International Development (DFID).[2] |
2013 | SCI announces that it has facilitated delivery of its 100 millionth treatment of praziquantel against schistosomiasis thanks to funding from private donations.[2] |
2016 | SCI reaches an annual delivery of over 50 million treatments for schistosomiasis and soil-transmitted helminths.[2] |
2018 | SCI facilitates the delivery of its 200 millionth treatment against parasitic worm infections.[2] |
Full timeline
Year | Month and date | Event type | Details | Location |
---|---|---|---|---|
2002 | SCI is founded through a US$32 million grant from the Bill and Melinda Gates Foundation[1], to tackle schistosomiasis in sub-Saharan Africa, where infected people are unable to afford the drugs needed for treatment.[3][4] | |||
2002 | Expansion | SCI begins program in Uganda, the first operating country.[5] | Uganda | |
2003 | October | Program | SCI selects six countries for full support: Uganda, Burkina Faso, Niger, Mali, Tanzania, and Zambia. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.[6] | |
2003 | Expansion | SCI begins program in Zambia, Zanzibar, and Niger.[5][7][8][9] | Zambia, Zanzibar, Niger | |
2006 | Funding | SCI receives large grants from the United States Agency for International Development and the Bill & Melinda Gates Foundation to support integrated NTD programs in eight countries for five years to treat lymphatic filariasis, onchocerciasis, and trachoma, in addition to schistosomiasis and soil-transmitted helminths.[1] | ||
2007 | Funding | SCI receives a grant to expand its work to Rwanda and Burundi.[1] | ||
2007 | Expansion | SCI program starts in Burundi.[5] | Burundi | |
2008 | Organization | The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) is established to answer strategic questions about schistosomiasis control.[10] | ||
2010 | Expansion | SCI begins working in Côte d'Ivoire.[1] | Côte d'Ivoire | |
2010 | Funding | SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[1] | ||
2010 | October | Funding | SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[11][1] | |
2010 | Statistics | The World Health Organization reports that schistosomiasis mortality could be as high as 280,000 per year in Africa alone.[12] | ||
2011 | Expansion | SCI begins program in Liberia, Malawi, and Mozambique.[5] | Liberia, Malawi, Mozanbique | |
2012 | Expansion | SCI program starts in Côte d'Ivoire, two years later due to political turmoil.[1][5] | Côte d'Ivoire | |
2012 | Expansion | SCI begins conversations with the Government of Ethiopia about starting a national schistosomiasis treatment program.[1] | Ethiopia | |
2012 | Coverage | SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.[13] | ||
2013 | April | Coverage | SCI announces that it has facilitated delivery of its 100 millionth treatment of praziquantel against schistosomiasis thanks to funding from private donations.[2] | |
2013 | Expansion | SCI begins first round of treatment in Ethiopia and Mauritania.[1][5][1][5] | Ethiopia, Mauritania | |
2013 | A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in sub-Saharan Africa and only 12.7% receiving preventive chemotherapy.[12] | |||
2013 – 2014 | Between November 2013 and April 2014 | SCI funds mapping in Ethiopia.[1] | Ethiopia | |
2014 | Expansion | SCI begins program in the Democratic Republic of the Congo and Madagascar.[5] | Democratic Republic of the Congo, Madagascar | |
2014 | Collaboration | SCI begins working with other partners in Côte d'Ivoire, including Sightsavers, the END Fund, and Helen Keller International on a more integrated neglected tropical diseases (NTD) program.[1] | ||
2014 | Funding | The British Department for International Development awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.[1] | ||
2014 | Coverage | ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.[13] | ||
2014 – 2015 | Coverage | SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.[1] | Côte d'Ivoire | |
2015 | Budget | SCI begins to use a system of country cashbooks for spending breakdown, which compare monthly in-country actual spending to budgets.[1] | ||
2015 | Coverage | ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.[13] | ||
2015 | Schistosomiasis is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.[12] | |||
2015 – 2016 | Program | SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.[1] | ||
2015 – 2016 | Between April 2015 and March 2016 | SCI spends around US$2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia during the period.[1] | Ethiopia | |
2015 – 2016 | Between April 2015 and March 2016 | Coverage | SCI reports having delivered 890,000 treatments in Uganda, out of 1.2 million planned treatments.[1] | |
2016 | Expansion | SCI begins program in Nigeria.[5] | Nigeria | |
2016 | January | Funding | Private foundation Good Ventures awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from GiveWell in 2015.[14] | |
2016 | August | Review | GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).[13] | |
2017 | January | Funding | Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.[15] | |
2017 | October | Budget | SCI estimates that it would cost US$0.24 on average per additional treatment delivered to a school-aged child.[1] | |
2017 | Budget | GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.[16] | ||
2018 | March | Funding | GiveWell allocates 100% of its discretionary fund to SCI, totalling US$5.6 million. It allocates a further $0.89 million to the SCI in the first quarter of 2018, which is 30% of its discretionary fund for that period.[16][17] | |
2018 | May | Funding | GiveWell allocates 30% of its US$3 million in discretionary fund to SCI.[17] | |
2018 | August | Funding | GiveWell allocates 30% of its US$4.1 million in discretionary fund to SCI.[17] | |
2018 | November | Funding | GiveWell recommends that Good Ventures grant $2.5 million to SCI.[18][19] | |
2019 | March | Funding | GiveWell updates its estimate of SCI's room for more funding from US$16.8 million to $28.7 million as a result of incorporating SCI's updates to its projections for how much funding it expects to receive from other funders over the next few years.[1] |
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by User:Sebastian.
Funding information for this timeline is available.
Feedback and comments
Feedback for the timeline can be provided at the following places:
- FIXME
What the timeline is still missing
Timeline update strategy
See also
External links
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 "Schistosomiasis Control Initiative: Supplementary Information". givewell.org. Retrieved 11 March 2019.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 "SCI". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019.
- ↑ "Ten million Africans treated by international disease treatment programme". imperial.ac.uk. Retrieved 12 March 2019.
- ↑ Adenowoa, Abiola Fatimah; Oyinloyea, Babatunji Emmanuel; Ogunyinkaa, Bolajoko Idiat; Kappo, Abidemi Paul. "Impact of human schistosomiasis in sub-Saharan Africa". Brazilian Journal of Infectious Diseases. doi:10.1016/j.bjid.2014.11.004.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 "OUR REACH". schistosomiasiscontrolinitiative.org. Retrieved 12 March 2019.
- ↑ "Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016". givewell.org. Retrieved 12 March 2019.
- ↑ "ZAMBIA". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019.
- ↑ "ZANZIBAR". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019.
- ↑ "NIGER". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019.
- ↑ Ezeamama, Amara E.; He, Chun-La; Shen, Ye; Yin, Xiao-Ping; Binder, Sue C.; CampbellJr., Carl H.; Rathbun, Stephen; Whalen, Christopher C.; N’Goran, Eliézer K.; Utzinger, Jürg; Olsen, Annette; Magnussen, Pascal; Kinung’hi, Safari; Fenwick, Alan; Phillips, Anna; Ferro, Josefo; Karanja, Diana M. S.; Mwinzi, Pauline N. M.; Montgomery, Susan; Secor, W. Evan; Hamidou, Amina; Garba, Amadou; King, Charles H.; Colley, Daniel G. "Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries". doi:10.1186/s12879-016-1575-2.
- ↑ "Imperial initiative to protect children from tropical disease awarded £25m government backing". imperial.ac.uk. Retrieved 11 March 2019.
- ↑ 12.0 12.1 12.2 Savioli, Lorenzo; Albonico, Marco; Colley, Daniel G.; Correa-Oliveira, Rodrigo; Fenwick, Alan; Green, Will; Kabatereine, Narcis; Kabore, Achille; Katz, Naftale; Klohe, Katharina; LoVerde, Philip T.; Rollinson, David; Russell Stothard, J.; Tchuem Tchuenté, Louis-Albert; Waltz, Johannes; Zhou, Xiao-Nong. "Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty". PMC 5363045. PMID 28330495. doi:10.1186/s40249-017-0280-8.
- ↑ 13.0 13.1 13.2 13.3 "SCHISTOSOMIASIS CONTROL INITIATIVE". givingwhatwecan.org. Retrieved 12 March 2019.
- ↑ "Schistosomiasis Control Initiative — General Support (2016)". openphilanthropy.org. Retrieved 11 March 2019.
- ↑ "Schistosomiasis Control Initiative — General Support (2017)". openphilanthropy.org. Retrieved 11 March 2019.
- ↑ 16.0 16.1 "HOW YOUR MONEY IS SPENT". schistosomiasiscontrolinitiative.org. Retrieved 15 March 2019.
- ↑ 17.0 17.1 17.2 "Discretionary Grantmaking". givewell.org. Retrieved 19 April 2019.
- ↑ "2018 Allocation to GiveWell Top Charities". openphilanthropy.org. Retrieved 20 April 2019.
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedgivewell